Circulating levels of adiponectin were lower in CAD (8.51 ± 0.24) and CAD+T2DM (9.17 ± 0.33) than in the control category (11.36 ± 0.42; p < 0.001; Fig 2A). This evidence concerns the gene ADIPOQ and coronary artery disorder.